Private company

Apogee Therapeutics, Inc.

Last updated Oct 16, 2026.

Overview

-$255.8MNet income, fiscal 20252
  • IndustryBiological Products, (No Diagnostic Substances)
  • Business address1 Letterman Drive, Building B, San Francisco, Ca3
  • Filer categoryLarge accelerated filer3

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

-$232.6MFree cash flow2

Financial statements

Operating income2-$285.6M in 2025+207% since 2023
-$300.0M-$200.0M-$100.0M02023: -$93.0M-$93.0M20232024: -$216.9M-$216.9M2024+133%2025: -$285.6M-$285.6M2025+32%
Net income2-$255.8M in 2025+205% since 2023
-$300.0M-$200.0M-$100.0M02023: -$84.0M-$84.0M20232024: -$182.1M-$182.1M2024+117%2025: -$255.8M-$255.8M2025+40%
Fiscal year2022202320242025
Research and development$68.4M2$167.9M2$214.7M2
Operating income-$93.0M2-$216.9M2-$285.6M2
Income tax$02$18.0K2$278.0K2
Net income-$84.0M2-$182.1M2-$255.8M2
Earnings per share-$3.362-$3.302-$4.222
Earnings per share (diluted)-$3.362-$3.302-$4.222

Compare Apogee Therapeutics, Inc. with another company

Former names

  • Apogee Therapeutics, LLCApr 28, 2023 to Jun 12, 20233

Recent filings

  1. Sep 3, 20268-K
  2. Sep 3, 20264
  3. Sep 3, 20264
  4. Sep 3, 20264
  5. Sep 3, 20264
  6. Sep 3, 20264
  7. Sep 3, 20264
  8. Sep 3, 20264
  9. Sep 3, 20264
  10. Sep 3, 20264 OWNERSHIP DOCUMENT
  11. Aug 11, 20268-K
  12. Aug 11, 20264 OWNERSHIP DOCUMENT
  13. Aug 10, 20268-K
  14. Aug 10, 202610-Q
  15. Aug 7, 20264 OWNERSHIP DOCUMENT

Every filing from the last three years, summarized. The full record is on SEC EDGAR.1

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9